SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-08-004298
Filing Date
2008-04-08
Accepted
2008-04-08 17:05:43
Documents
6
Period of Report
2008-05-15
Effectiveness Date
2008-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2184469zdef14a.htm DEF 14A 1435544
2 G91552BGI001.JPG g91552bgi001.jpg GRAPHIC 2472
3 G701603.JPG g701603.jpg GRAPHIC 6074
4 G234598.JPG g234598.jpg GRAPHIC 2909
5 G600506.JPG g600506.jpg GRAPHIC 3813
6 G141903.JPG g141903.jpg GRAPHIC 727
  Complete submission text file 0001047469-08-004298.txt   1459633
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19319 | Film No.: 08745843
SIC: 2834 Pharmaceutical Preparations